Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study

키워드

참고문헌 (27)

1. EBCTCG(Early Breast Cancer Trialists' Collaborative Group), "Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality : metaanalysis of individual patient data for 8135 women in 22 randomised trials", Lancet, 383, pp.2127~2135 (2014)
2. Coates AS, "Tailoring therapies : improving the management of early breast cancer : St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015", Ann Oncol, 26, pp.1533~1546 (2015)
3. Poortmans PM, "Internal mammary and medial supraclavicular irradiation in breast cancer", N Engl J Med, 373, pp.317~327 (2015)
4. Whelan TJ, "Regional nodal irradiation in early-stage breast cancer", N Engl J Med, 373, pp.307~316 (2015)
5. Mannino M, "Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld", Radiother Oncol, 90, pp.14~22 (2009)
6. Livi L, "Loco regional failure pattern after lumpectomy and breast irradiation in 4, 185 patients with T1 and T2 breast cancer : implications for nodal irradiation", Acta Oncol, 45, pp.564~570 (2006)
7. Reddy SG, "Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation", Breast J, 13, pp.12~18 (2007)
8. Galper S, "Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone", Int J Radiat Oncol Biol Phys, 45, pp.1157~1166 (1999)
9. Yu JI, "Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer", Int J Radiat Oncol Biol Phys, 78, pp.1135~1141 (2010)
10. Yates L, "Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes", Int J Radiat Oncol Biol Phys, 82, pp.2093~2103 (2012)
11. Truong PT, "Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy", Int J Radiat Oncol Biol Phys, 73, pp.357~364 (2009)
12. National Cancer Institute, "Common Terminology Criteria for Adverse Events (CTCAE) version 4.0" (2009), U.S. Department of Health and Human Services
13. Xie L, "Elective regional nodal irradiation in patients with early-stage breast cancer", Semin Radiat Oncol, 21, pp.66~78 (2011)
14. Jagsi R, "Progress and controversies : radiation therapy for invasive breast cancer", CA Cancer J Clin, 64, pp.135~152 (2014)
15. Whelan TJ, "NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer", J Clin Oncol, 29(15 Suppl), pp.LBA1003~ (2011)
16. Tanis PJ, "Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy", J Am Coll Surg, 192, pp.399~409 (2001)
17. Estourgie SH, "Lymphatic drainage patterns from the breast", Ann Surg, 239, pp.232~237 (2004)
18. Belkacemi Y, "Patterns of practice of regional nodal irradiation in breast cancer : results of the European Organization for Research and Treatment of Cancer(EORTC)NOdal Radiotherapy(NORA)survey", Ann Oncol, 26, pp.529~535 (2015)
19. Wai ES, "Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes", Radiother Oncol, 97, pp.301~306 (2010)
20. Early Breast Cancer Trialists' Collaborative Group(EBCTCG), "Comparisons between different polychemotherapy regimens for early breast cancer : meta-analyses of long-term outcome among 100, 000 women in 123 randomised trials", Lancet, 379, pp.432~444 (2012)
21. Qin YY, "Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients", PLoS One, 6, pp.e26946~ (2011)
22. Mamounas EP, "Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer : results from NSABP B-28", J Clin Oncol, 23, pp.3686~3696 (2005)
23. Sartor CI, "Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer : cancer and leukemia group B 9344", J Clin Oncol, 23, pp.30~40 (2005)
24. Romond EH, "Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer", N Engl J Med, 353, pp.1673~1684 (2005)
25. Cuzick J, "Statistical controversies in clinical research : longterm follow-up of clinical trials in cancer", Ann Oncol, 26, pp.2363~2366 (2015)
26. Mamounas EP, "Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer : results from NSABP B-14 and NSABP B-20", J Clin Oncol, 28, pp.1677~1683 (2010)
27. Drukker CA, "Gene expression profiling to predict the risk of locoregional recurrence in breast cancer : a pooled analysis", Breast Cancer Res Treat, 148, pp.599~613 (2014)

관련 논문AI추천